NCT05269160View on ClinicalTrials.gov

Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

April 24, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2028

Conditions
Radiation DermatitisBreast Cancer
Interventions
DRUG

Dermaprazole 1%

Dermaprazole cream at a concentration of 1% will be applied to the irradiated area twice daily for up to 7 weeks

DRUG

Dermaprazole 2%

Dermaprazole cream at a concentration of 2% will be applied to the irradiated area twice daily for up to 7 weeks

Trial Locations (3)

77030

RECRUITING

Baylor College of Medicine Medical Center - McNair Campus, Houston

RECRUITING

Baylor St. Luke's Medical Center, Houston

77054

RECRUITING

Harris Health System - Smith Clinic, Houston

All Listed Sponsors
lead

Michelle S Ludwig

OTHER